Received May 15, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | — |
COVID after Pfizer Boosters; COVID after Pfizer Boosters; SUPPORT PROGRAM This is a solicited report received from a Consumer or other non HCP, Program ID. A 37-year-old female patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant), outcome "unknown" and all described as "COVID after Pfizer Boosters". The clinical course was reported as follows: The patient thought she had given it to her mother and her in-law COVID for holiday. She felt bad, but they'll get over it. She was just hoping they came out okay. She took the easy route, she got the boosters, so it was not as bad as it could had been. The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.; Sender's Comments: Based on plausible dose -event relationship post vaccination and no other alternate explanation the causal role of BNT162b2 (BNT162B2 NOS) cannot be excluded for the reported LOE events.